Calypte Biomedical Corp (fka CYPT)

[scion]

Calypte Biomedical Corp · S-8 · On 3/28/3 · EX-4.1
SEC File 333-104113 · Accession Number 898430-3-2160

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan · Form S-8

2: EX-4.1 Advisory and Consulting Agreement
3: EX-4.1(A) Consulting Agreement - Howard Schraub
4: EX-4.1(B) Amended Consulting Agreement - George Furla
5: EX-4.1(C) Amended Consulting Agreement - V.T. Franzke
6: EX-4.1(D) Consulting Agreement - Mohamed Hadid
7: EX-4.1(E) Amended Consulting Agreement - Hendrix Bodden
8: EX-4.1(F) Consulting Agreement - Cliff Brune
9: EX-4.1(G) Amended Consulting Agreement - Ronald Mink
10: EX-4.1(H) Amended Consulting Agreement - Michael Sitrick
11: EX-4.1(I) Amended Consulting Agreement - Denise
Lescasse-Laurent
12: EX-4.1(J) Amended Consulting Agreement - Keith Lippert
13: EX-4.2 Form of Warrant
14: EX-5.1 Opinion of Naccarato & Associates
15: EX-23.1 Consent of Kpmg

--------------------------------------------------------------------------------
EX-4.1 · Advisory and Consulting Agreement


Number of Shares and Warrants

--------------------------------------------------------------------------------

4.1(a)
10,000,000

4.1(b)
10,000,000

4.1(c)
10,000,000

4.1(d)
8,000,000

4.1(e)
1,000,000

4.1(f)
240,000

4.1(g)
1,131,000

4.1(h)
1,800,000

4.1(i)
791,000

4.1(j)
1,650,000

Other
200,000


--------------------------------------------------------------------------------

Total
44,812,000


--------------------------------------------------------------------------------
http://www.secinfo.com/drdbh.223v.d.htm#1stPage